{"entity":{"id":"paper-msibi-cervical-cancer-survival-eswatini-pgph-2026","kind":"paper","name":"Survival of women with cervical cancer in the Eswatini cancer registry, 2016 to 2024","aka":[],"tldr":"Among 2,349 women with cervical cancer in Eswatini's registry from 2016 to 2024, 59% did not receive any treatment. Stage at diagnosis and whether a woman was treated were the strongest predictors of survival.","summary":"Published as \"Predictors of survival among cervical cancer patients in Swaziland (Eswatini): A population-based analysis in a resource-limited setting (2016-2024)\". The authors screened the Eswatini cancer registry for 2016 to 2024, found 2,349 women with cervical cancer, and analysed 603 deaths with a Cox proportional hazards model, adjusting for age, smoking, HIV status, treatment and basis of diagnosis. They describe it as the first survival analysis of cervical cancer in Eswatini.","asOf":"2026-11-16","links":[{"label":"PLOS Glob Public Health 2026","url":"https://doi.org/10.1371/journal.pgph.0006309"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/41990049/"}],"tags":[],"related":["paper-vilakati-early-onset-cervical-cancer-eswatini-canep-2026","manzini-oncology-unit"],"cancers":["cervical"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["eswatini-national-cancer-registry","eswatini-ministry-of-health"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"journal":"PLOS Global Public Health","year":2026,"doi":"10.1371/journal.pgph.0006309","pmid":"41990049","authors":"Msibi SS, Lopez C, Khumalo FN, Su LJ.","paperType":"observational","findings":["44.27% of the women were aged 50 or older at diagnosis, 31.42% were 40 to 49 and 24.31% were 39 or younger.","59.05% did not receive any treatment.","In this registry group (2016 to 2024), median survival was about 40 months for women diagnosed at stage 1 and about 10 months at stage 4. A median is the middle of a group: half lived longer. The abstract does not say whether the medians describe all 2,349 women or the 603 whose deaths were analysed.","Treatment (chemotherapy, radiation or surgery) reduced the hazard of death by 30% (hazard ratio 0.70, 95% CI 0.59 to 0.84)."],"whatItMeans":"The registry now holds enough years of data to show where the losses are: late diagnosis and no treatment. Both are things screening, referral and a radiotherapy service inside the country are meant to change.","caveats":["Registry data, in a country where the Ministry of Health says cancer is not legally notifiable and private-sector reporting is limited.","The abstract reports 603 deaths analysed; follow-up of women who left care is not described there."],"participants":2349},"route":"/key-papers/paper-msibi-cervical-cancer-survival-eswatini-pgph-2026/","neighbours":{"paper":[{"id":"paper-vilakati-early-onset-cervical-cancer-eswatini-canep-2026","kind":"paper","name":"Cervical cancer by age at diagnosis in the Eswatini National Cancer Registry, 2016 to 2022","route":"/key-papers/paper-vilakati-early-onset-cervical-cancer-eswatini-canep-2026/"}],"institution":[{"id":"eswatini-national-cancer-registry","kind":"institution","name":"Eswatini National Cancer Registry","route":"/institutions/eswatini-national-cancer-registry/"},{"id":"manzini-oncology-unit","kind":"institution","name":"Manzini Oncology Unit","route":"/institutions/manzini-oncology-unit/"},{"id":"eswatini-ministry-of-health","kind":"institution","name":"Ministry of Health, Eswatini","route":"/institutions/eswatini-ministry-of-health/"}],"cancer":[{"id":"cervical","kind":"cancer","name":"Cervical cancer","route":"/cancers/cervical/"}]}}